Supply Chain

Company garners a Best Air Cargo Carrier-NA award in Hong Kong

Your serialization systems aren’t as interoperable as you might think

FDA-accepted pilot projects hope to demonstrate how industry compliance could be realized by the 2023 deadline

A complement to the classic randomized clinical trial may benefit drug commercialization

Contract logistics provider will have 30 facilities by the end of this year

$5.7-billion purchase to close in late 2019

New science breakthroughs, and easy access to financing, propel this year’s M&A and licensing market

Will retain position until May 2020

Business opportunities expand, include selling healthcare data to researchers

10th edition of the Biopharma Cold Chain Sourcebook predicts above-average growth

Combining sublingual nitroglycerin and aspirin in a tablet or other embodiments could be a significant global market opportunity

Lawsuit to recover $221,000 in losses filed against Agility Logistics, Hapag-Lloyd and the port

Hub provider and software company will partner for advancing cellular and genetic therapies (CGTs)

The Pharmaceutical Distribution Security Alliance proposes an industry governance process

While operating under an FAA pilot program, UPS will gear up for commercial deliveries

Acquires Astero Bio Corp., developer of thawing devices

$1-million capital investment in temperature-controlled storage for life sciences and retail

Winners were announced at HDA 2019 Distribution Management Conference

Multiple locations in Mexico and Brazil can now be served more quickly

Three more locations join continents

Company touts 12 months of rapid growth

The advantages of aligning patient recruitment and supply data

Walgreens is one of the retailers joining in the testing program

Regulation enables better coordination of where opioids are going

The goal of producing meaningful data is driving industry progress

Issues include apparently diverted opioids and mislabeled medications

As the definition of ‘targeted’ therapies—especially in oncology—and as a component of companion diagnostics, biomarkers are creating opportunities in drug research and commercialization